Introduction
Epithelial ovarian carcinoma is one of the most common gynecological malignancies, and the fifth most frequent cause of cancer death in women (Siegel et al., 2014) . The current standard treatments for ovarian cancer patients rely on surgery following by chemotherapy. However, chemotherapeutical drugs resistance and early metastasis caused its poor prognosis (Sun et al., 2013) . The survival rate of ovarian cancer patients is only 40% in all stages and 15%-30% patients with widespread metastatic disease survive 5 years after the initial treatment (Vaughan et al., 2011) . Mortality risk increased 3.44-fold in patients over 50 years of age, 2.75 times in the presence of lymph node invasion (Arikan et al., 2014) .
The metastasis and invasion of ovarian cancer is a complex and multistage process which depend on the activity of many mediators. Previous studies have shown that extracellular matrix (ECM) plays an important role in tumor invasion and metastasis (Stallings-Mann and Radisky, 2007; Kessenbrock et al., 2010) . The MMPs are a family of structurally conserved, zinc-dependent endopeptidases, which are involved in proteolytic modeling of the ECM. MMP-9 can degrade components of the ECM, which constitutes an important barrier to tumor cell invasion (Liotta and Stetler-Stevenson, 1990; Himelstein et al., 1994 (Hu et al., 2012) .
Chinese herbal medicine had been confirmed to have anti-tumor activities in recent years (Sengupta et al., 2001; Kanazawa et al., 2003; Hsu et al., 2005) . Rosa roxburghii Tratt, which grown in Southwest China, contains high percentage of polysaccharides and vitamin C. Studies showed that Rosa roxburghii Tratt extracts displayed anti-tumor effects and induced apoptosis of cancer cells (Ma et al., 1997; Liu et al., 2012) . However, the effects and mechanisms of Rosa roxburghii Tratt polysaccharides on metastasis and invasion of ovarian cancer are still not clear. The present study was performed to evaluate antimetastatic effects of Rosa roxburghii Tratt polysaccharides for ovarian carcinoma and explore molecular mechanisms in vitro.
Materials and Methods

Regents and chemicals
Dulbecco's modified Eagle's medium (DMEM) and fetal bovine serum (FBS) were obtained from Gibco, American. Matrigel and transwells were purchased from BD Biosciences, American. Antibodies against MMP-9 and β-actin were obtained from Ptoteintech, China. The enhanced chemiluminescence (ECL) kit was from Amersham Life Science, UK.
Preparation of crude polysaccharide from Rosa roxburghii Tratt (CLP)
The dried fruits of Rosa roxburghii Tratt were obtained from Guizhou, China. The crude polysaccharides were isolated as previously described (Yang et al., 2010) . Briefly, the dried powder of Rosa roxburghii Tratt (100g) were extracted in a Soxhlet's apparatus with ligroin and 95% alcohol. After the mixture was filtered, the residues were dried and then were extracted with hot water (1:15, w/v) at 100°C for three times (1h each time). The combined extracts were pooled, concentrated to 40% of the original volume. The concentrated solution was dialyzed for 1 day against distilled water and twice volumes of 95% alcohol were added to precipitate the polysaccharides, and then at 4°C overnight. Finally polysaccharide pellets were obtained by centrifugation at 4000 rpm for 15 min and repeatedly washed sequentially with anhydrous ethanol, acetone and diethyl ether. Finally, the filtrate was lyophilised to yield the crude polysaccharides (CLP) which dissolved in DMEM with 10% FBS for further use. The yield of crude polysaccharides was 6.8% and the percentage of total sugar was about 76%. There was no absorption at 260 and 280nm in the crude polysaccharides, suggesting no contamination of nucleic acid and protein.
Cell culture
The epithelial ovarian cancer A2780 cell line was obtained from ATCC. A2780 cells were maintained in DMEM media (Gibco, USA) supplemented with 10% FBS at 37°C in with 5% CO 2 . Cells were stored with 10% DMSO (Tianjin, China).
MTT assay A2780 cells were planted into 96-well plates and attached for 24h. The cells were then treated with different concentrations of CLP for 48h. The MTT solution (5mg/ ml) was added to each well and incubated 4 h at 37ºC. Then, 150μl of DMSO was added into each well and mixed for 10 minute at 37ºC. The optical density (OD) was determined by spectrophotometer (Shanghai, China) at 490 nm. Cells without CLP were used as the negative control. Each assay was performed triplicate.
Wound healing assay
5×10 5 cells were seeded into 6 well plates and grown to 70-80% confluence. The cell monolayer was scratched using a 200 µl sterile pipette tip. Cells were then washed twice with PBS. Ovarian cancer cells were treated with 0, 100 μg/ml and 200 μg/ml CLP solution for 24h. Cell migration of ovarian cancer cells was observed under a phase-contrast microscope at 100× magnification field at 0 and 24h post-induction of injury. Migrated cells into the denuded area in each of six random fields were measured and quantified with computer-assisted microscope.
Invasion assays
Cell invasion were detected by the Transwell assay. Ovarian cancer cells were treated with 0, 100 μg/ml and 200 μg/ml CLP solution for 24h. Ovrian cancer cells were added to the upper chamber with serum-free DMEM medium. The cells migrated to the lower chamber whiched filled with 10% FBS DMEM medium as a chemoattactant. After 24h treatment, cells on the upper surface of membrane were cleared and the cells on the underside of membrane were stained with 0.1% crystal violet for 10min. The migrated cells of radom six fields of each Transwell membrane were counted under a microscope at 100× magnification field.
Western blot analysis
The total cell lysates were separated by 10% SDS-PAGE and then transferred to nitrocellulose membrane by semi-dry apparatus for 45 min. The membrane was blocked with 5% non-fat milk for 1.5h and then incubated with the specific primary antibody solution overnight at 4℃. After incubation with secondary antibody for 1 h, the protein bands were visualized by ECL kit.
Data analysis
Data are presented as mean±SED for three independent experiments and then analyzed Data using one-way analysis of variance (ANOVA) by SPSS 13.0 software. The value of p<0.05 was considered statistically significant.
Results
The effects of CLP on ovarian cancer proliferation
The growth curves of ovarian cancer cells following various concentrations of CLP for 48h were shown in Figure 1 . CLP showed potent cytotoxic activity in ovarian cancer A2780 cells. There was a significantly, dosedependent decrease in proliferation of cells incubated with CLP (p<0.05). CLP with the concentration higher than 200μg/ml has cytotoxic effective on A2780 cells (Figure 1 ).
Effects of CLP on ovarian cancer cell movement
To investigate whether CLP could affect ovarian cancer cell movement, wound healing assay were performed. In the wound healing assay, CLP solution dose dependently decreased the movement of A2780 cells contrast with control group (Figure 2A) . The wound closure rates of CLP (100 μg/ml and 200 μg/ml) treated cells were 10.5% and 8.5% respectively which were significant lower than that of non-treated cells (p<0.05) ( Figure 2B ). :http://dx.doi.org/10.7314/APJCP.2014.15.23 
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Effects of CLP on ovarian cancer invasion
In the transwell assay, CLP significantly inhibited ovarian cancer cells migration and invasion in a dose dependent manner for 24h ( Figure 3A) . Treatment with 100 μg/ml and 200 μg/ml CLP inhibited cell migration by 37.56% and 30.85% respectively ( Figure 3B ). Transwell chamber assay suggested that CLP suppressed the invasion and metastasis of ovarian cancer.
Effects of CLP on the expression of MMP-9 in A2780 cell
To further understand the mechanisms of CLP induced surpression of invasion in ovarian cancer cells, the expression of metastasis related gene MMP-9 was examined with Western blotting. As compared to untreated cells, the expression of MMP-9 decreased after treatment with CLP for 24 h (Figure 4 ).
Discussion
Ovarian cancer is the most lethal of the gynecologic cancer due to the late diagnose. For the ovarian cancer patients at metastatic stage, there were limited effective therapies (Goff et al., 2007; Dinh et al., 2008; Jemal et al., 2008) . In addition, both patients and gynecologists had to face the serious side effect of chemotherapy (Shan et al., 2012) . Therefore, finding some new agents which had better anti-tumor effect without toxicities is an urgent for ovarian cancer patients.
Regents with natural origin are the preferred priority in the drug screening programs. Several medicinal plants had been used traditionally for the prevention and treatment of cancer (Alabsi et al., 2013) . Rosa Roxburghii Tratt is a rare fruit crop in Southwest China which has been used to improve immune response, anti-aging and enhancing digestive ability in Chinese medicine (Zhang et al., 2001; Huang et al., 2014) . In this study, we explored the antimetastatic effect of CLP on ovarian cancer cells in vitro and the mechanisms underlying this process.
Rose Roxburghii Tratt extracts combined with Fagopyrum Cymosum has been reported to inhibit tumor growth and induce apoptosis effects on human esophageal squamous carcinoma CaEs-17, human gastric carcinoma SGC-7901 and pulmonary carcinoma A549 cells (Liu et al., 2012) . Our data showed that CLP also significantly inhibited cell proliferation of ovarian cancer cells from 200μg/ml and the cell survival rate decreased in dose dependent manner.
Moreover, we firstly found that CLP can effectively prevent the migration and invasion of ovarian cancer cells. Insight into molecular mechanisms indicated that CLP decreased MMP-9 expression. MMP-9 were reported to be related with tumor invasion because it can degrade the basement membrane collagen (Parmo-Cabanas et al., 2006) . Increased expression of MMP-9 was associated with poor prognosis in ovarian cancer patients. Down regulation of MMP-9 may contribute to improve outcome of ovarian cancer (Li et al., 2013) . Our data suggested that CLP suppressed ovarian cancer A2780 cells invasion through down-regulated MMP-9 expression. The exact substances in the crude CLP responsible for this process were not be elucidated in this study and need further investigation. In the conclusion, our results demonstrated that CLP could inhibit proliferation of ovarian cancer. In addition, CLP prevent migration and invasion of ovarian cancer by decreasing MMP-9 expression. Therefore, we believed that CLP which did not have serious side-effects may develop as novel alterative drug for ovarian cancer patients especially at metastatic stage.
